M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Osiris Therapeutics names Hansjörg Wyss as strategic advisor
Stem cell company Osiris Therapeutics (NasdaqGM:OSIR) revealed on Thursday the addition of Hansjörg Wyss as its strategic advisor.
Previously, Wyss was the founder, chairman, CEO and a major shareholder of Synthes until it was sold to Johnson & Johnson in 2012.
The company added that...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives